LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities.

    Christov, Marta / Clark, Abbe R / Corbin, Braden / Hakroush, Samy / Rhee, Eugene P / Saito, Hiroaki / Brooks, Dan / Hesse, Eric / Bouxsein, Mary / Galjart, Niels / Jung, Ji Yong / Mundel, Peter / Jüppner, Harald / Weins, Astrid / Greka, Anna

    JCI insight

    2018  Volume 3, Issue 4

    Abstract: ... to drive progressive CKD and osteodystrophy in the absence of interstitial fibrosis. This work introduces ... for podocyte-protective strategies for future kidney therapeutics. ... to the surprising observation that podocyte ablation and the resulting glomerular filter destruction is sufficient ...

    Abstract Progressive chronic kidney diseases (CKDs) are on the rise worldwide. However, the sequence of events resulting in CKD progression remain poorly understood. Animal models of CKD exploring these issues are confounded by systemic toxicities or surgical interventions to acutely induce kidney injury. Here we report the generation of a CKD mouse model through the inducible podocyte-specific ablation of an essential endogenous molecule, the chromatin structure regulator CCCTC-binding factor (CTCF), which leads to rapid podocyte loss (iCTCFpod-/-). As a consequence, iCTCFpod-/- mice develop severe progressive albuminuria, hyperlipidemia, hypoalbuminemia, and impairment of renal function, and die within 8-10 weeks. CKD progression in iCTCFpod-/- mice leads to high serum phosphate and elevations in fibroblast growth factor 23 (FGF23) and parathyroid hormone that rapidly cause bone mineralization defects, increased bone resorption, and bone loss. Dissection of the timeline leading to glomerular pathology in this CKD model led to the surprising observation that podocyte ablation and the resulting glomerular filter destruction is sufficient to drive progressive CKD and osteodystrophy in the absence of interstitial fibrosis. This work introduces an animal model with significant advantages for the study of CKD progression, and it highlights the need for podocyte-protective strategies for future kidney therapeutics.
    MeSH term(s) Animals ; Bone Resorption/blood ; Bone Resorption/etiology ; Bone Resorption/pathology ; CCCTC-Binding Factor/deficiency ; CCCTC-Binding Factor/genetics ; Calcification, Physiologic/genetics ; Disease Models, Animal ; Disease Progression ; Female ; Fibroblast Growth Factors/blood ; Glomerular Filtration Rate ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Parathyroid Hormone/blood ; Podocytes/pathology ; Renal Insufficiency, Chronic/blood ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/genetics ; Renal Insufficiency, Chronic/pathology
    Chemical Substances CCCTC-Binding Factor ; Ctcf protein, mouse ; Parathyroid Hormone ; Fibroblast Growth Factors (62031-54-3) ; fibroblast growth factor 23 (7Q7P4S7RRE)
    Language English
    Publishing date 2018-02-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.95091
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities

    Marta Christov / Abbe R. Clark / Braden Corbin / Samy Hakroush / Eugene P. Rhee / Hiroaki Saito / Dan Brooks / Eric Hesse / Mary Bouxsein / Niels Galjart / Ji Yong Jung / Peter Mundel / Harald Jüppner / Astrid Weins / Anna Greka

    JCI Insight, Vol 3, Iss

    2018  Volume 4

    Abstract: ... to drive progressive CKD and osteodystrophy in the absence of interstitial fibrosis. This work introduces ... for podocyte-protective strategies for future kidney therapeutics. ... to the surprising observation that podocyte ablation and the resulting glomerular filter destruction is sufficient ...

    Abstract Progressive chronic kidney diseases (CKDs) are on the rise worldwide. However, the sequence of events resulting in CKD progression remain poorly understood. Animal models of CKD exploring these issues are confounded by systemic toxicities or surgical interventions to acutely induce kidney injury. Here we report the generation of a CKD mouse model through the inducible podocyte-specific ablation of an essential endogenous molecule, the chromatin structure regulator CCCTC-binding factor (CTCF), which leads to rapid podocyte loss (iCTCFpod–/–). As a consequence, iCTCFpod–/– mice develop severe progressive albuminuria, hyperlipidemia, hypoalbuminemia, and impairment of renal function, and die within 8–10 weeks. CKD progression in iCTCFpod–/– mice leads to high serum phosphate and elevations in fibroblast growth factor 23 (FGF23) and parathyroid hormone that rapidly cause bone mineralization defects, increased bone resorption, and bone loss. Dissection of the timeline leading to glomerular pathology in this CKD model led to the surprising observation that podocyte ablation and the resulting glomerular filter destruction is sufficient to drive progressive CKD and osteodystrophy in the absence of interstitial fibrosis. This work introduces an animal model with significant advantages for the study of CKD progression, and it highlights the need for podocyte-protective strategies for future kidney therapeutics.
    Keywords Endocrinology ; Medicine ; R
    Subject code 616
    Language English
    Publishing date 2018-02-01T00:00:00Z
    Publisher American Society for Clinical investigation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top